COVID-19
-
People with mild to moderate COVID-19 can shed viral RNA in their feces months after initial infection, Stanford researchers find. Those who do often have nausea, vomiting and abdominal pain.
-
Students create low-tech antiviral method
Using household items, Stanford students have developed a way to make affordable nasal drops with the potential to slow the spread of viruses like COVID-19.
-
Vaccines bolster immunity from prior infection
Two-dose COVID-19 vaccines significantly increase protection against hospitalization and death in people who had the illness before they were immunized.
-
The pandemic turns 2
Stanford Medicine scientists explain what we know, and what we don’t know, about living with COVID-19 two years after the World Health Organization declared a pandemic.
-
Lab processes 1 millionth COVID-19 test
Stanford Medicine’s clinical virology laboratory has processed its 1 millionth COVID-19 test nearly two years after becoming one of the first academic center testing sites in the country.
-
Vaccination protects better than infection
COVID-19 vaccines are better than infection at making antibodies to recognize new viral variants, according to a Stanford study.
-
Cancer drug renders COVID vaccine ineffective
Rituximab, a drug widely used in patients with lymphoma, blunts or eliminates the antibody response to COVID-19 vaccines if it is administered before them, Stanford researchers say.
-
Antibodies may predict COVID-19 severity
A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe symptoms.
-
Grant for faculty family care
The Doris Duke foundation has awarded the Stanford School of Medicine $550,000 to aid physician-scientists with family caregiving responsibilities heightened by COVID-19.
-
Surgery rates rebounded quickly in pandemic
After a dramatic drop in nonessential surgery rates early in the pandemic, U.S. hospitals quickly adapted to new safety protocols, and rates returned to normal, Stanford Medicine research shows.
-
Study: COVID-19 vaccine effective in cancer patients
The Moderna and Pfizer BioNTech vaccines prevented COVID-19 infection in cancer patients, particularly in those whose treatment concluded more than six months before vaccination, say researchers at Stanford, Harvard and the VA.
-
Smartwatch stress alerts
Stanford Medicine researchers created an algorithm to notify smartwatch wearers of stress, capturing events such as air travel, extended exercise and illness.
- Administration
- Aging
- Big Data
- Biochemistry
- Bioengineering
- Cancer
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- COVID-19
- Developmental Biology
- Education
- Genetics
- Global Health
- Health Policy
- Hearing
- Imaging
- Immunology
- Infectious Disease
- Mental Health
- Neuroscience
- Nutrition
- Obituaries
- Pain
- Patient Care
- Pediatrics
- Precision Health
- Preventive Medicine
- Sleep
- Stem Cells
- Surgery
- Technology
- Transplantation
- Urology
- Women's Health